Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
Linehan
W Marston
WM
Urologic Oncology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892-1501, USA. uob@nih.gov
Vasselli
James
J
Srinivasan
Ramaprasad
R
Walther
McClellan M
MM
Merino
Maria
M
Choyke
Peter
P
Vocke
Cathy
C
Schmidt
Laura
L
Isaacs
Jennifer S
JS
Glenn
Gladys
G
Toro
Jorge
J
Zbar
Berton
B
Bottaro
Donald
D
Neckers
Len
L
D018262:Adenocarcinoma, Clear Cell / Q000235:genetics / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000473:pathology; D005260:Female; D015316:Genetic Therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D008297:Male; D011506:Proteins / Q000235:genetics; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D025521:Tumor Suppressor Proteins / Q000235:genetics*; D044767:Ubiquitin-Protein Ligases / Q000235:genetics*; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D006623:von Hippel-Lindau Disease / Q000235:genetics
C476078:FLCN protein, human; C000715470:MAS1 protein, human; D011506:Proteins; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; C497446:VHL protein, human